Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like Arkis Biosciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology April 19, 2017 Sangamo Scores Bragging Rights for First-in-Human Gene Editing Trial November 14, 2017 <b>Victoria Laughman</b> Named Executive Vice President Of Sales For Opko Health's BioReference August 17, 2017
Arkis Biosciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology April 19, 2017
<b>Victoria Laughman</b> Named Executive Vice President Of Sales For Opko Health's BioReference August 17, 2017
